Marshall Wace North America’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-21,285
Closed -$82K 1490
2018
Q2
$82K Buy
21,285
+2,679
+14% +$11.1K ﹤0.01% 1325
2018
Q1
$78K Sell
18,606
-105,816
-85% -$576K ﹤0.01% 1376
2017
Q4
$691K Buy
124,422
+1,211
+1% +$5.26K ﹤0.01% 1070
2017
Q3
$369K Buy
+123,211
New +$1.66M ﹤0.01% 1112

Other funds holding OTIC

Marshall Wace North America's OTIC Position: Q3 2018 in Review

Marshall Wace North America sold out of Otonomy, Inc. (OTIC) in Q3 2018, closing a stake of 21,285 shares — an estimated $82K sold.

Marshall Wace North America first reported a position in OTIC in Q3 2017 and held it in 4 quarters. The position peaked at $691K in Q4 2017. 58 funds tracked by Wall St. Rank hold OTIC as of Q3 2018.

  • Marshall Wace North America reported no remaining Otonomy, Inc. position as of Q3 2018 after selling out during the quarter.
  • Marshall Wace North America sold 21,285 Otonomy, Inc. shares in Q3 2018, an estimated $82K.
  • Marshall Wace North America first reported a position in Otonomy, Inc. in Q3 2017 and held it in 4 quarters.
  • Marshall Wace North America's Otonomy, Inc. position peaked at $691K in Q4 2017.
  • 58 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2018.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.